These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2840850)

  • 1. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase.
    Portolani M; Pietrosemoli P; Cermelli C; Mannini-Palenzona A; Grossi MP; Paolini L; Barbanti-Brodano G
    Antiviral Res; 1988 Apr; 9(3):205-18. PubMed ID: 2840850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of novobiocin and other DNA gyrase inhibitors on virus replication and DNA synthesis in herpes simplex virus type 1-infected BHK cells.
    Francke B; Margolin J
    J Gen Virol; 1981 Feb; 52(Pt 2):401-4. PubMed ID: 6270241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the bacterial DNA gyrase inhibitors, novobiocin, nalidixic acid, and oxolinic acid, on oxidative phosphorylation.
    Gallagher M; Weinberg R; Simpson MV
    J Biol Chem; 1986 Jul; 261(19):8604-7. PubMed ID: 3013857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid.
    Ferrazzi E; Peracchi M; Biasolo MA; Faggionato O; Stefanelli S; Palù G
    Biochem Pharmacol; 1988 May; 37(9):1885-6. PubMed ID: 2837249
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.
    Sugino A; Peebles CL; Kreuzer KN; Cozzarelli NR
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4767-71. PubMed ID: 200930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.
    Gellert M; Mizuuchi K; O'Dea MH; Itoh T; Tomizawa JI
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4772-6. PubMed ID: 337300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of postreplication recombinational repair by DNA-gyrase antagonists in Escherichia coli.
    Priel E
    Cell Biol Int Rep; 1984 Sep; 8(9):773-86. PubMed ID: 6094020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of bacteriophage lambda with oxolinic and nalidixic acid.
    Vihanová D; Vondrejs V
    Folia Microbiol (Praha); 1974; 19(5):390-3. PubMed ID: 4611869
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxolinic acid-resistant mutants of Bacillus subtilis.
    Vazquez-Ramos JM; Mandelstam J
    J Gen Microbiol; 1981 Nov; 127(1):1-9. PubMed ID: 6279763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DNA gyrase inhibitors, nalidixic acid and oxolinic acid, prevent iron-mediated repression of catechol siderophore synthesis in Azotobacter vinelandii.
    Page WJ; Patrick J
    Biol Met; 1988; 1(1):57-61. PubMed ID: 2856355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of DNA gyrase inhibitors in a polyamine-auxotrophic strain of Escherichia coli.
    Duschak VG; Goldemberg SH
    Biochim Biophys Acta; 1987 Oct; 910(1):21-6. PubMed ID: 2820496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.
    Greenwood D
    Antimicrob Agents Chemother; 1978 Mar; 13(3):479-83. PubMed ID: 400825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of Escherichia coli DNA in vitro: inhibition by oxolinic acid.
    Staudenbauer WL
    Eur J Biochem; 1976 Mar; 62(3):491-7. PubMed ID: 770163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA gyrase and the supercoiling of DNA.
    Cozzarelli NR
    Science; 1980 Feb; 207(4434):953-60. PubMed ID: 6243420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nalidixic acid and oxolinic acid reversibly suppress 3-methylcholanthrene-induced cell transformation of BALB/3T3 mouse cells.
    Kaneko M; Horikoshi J
    Int J Cancer; 1988 Dec; 42(6):913-6. PubMed ID: 3192335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bacterial DNA gyrase inhibitors on DNA synthesis in mammalian mitochondria.
    Castora FJ; Vissering FF; Simpson MV
    Biochim Biophys Acta; 1983 Sep; 740(4):417-27. PubMed ID: 6309236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in synthesis and stability of sigma 32 on treatment with inhibitors of DNA gyrase in Escherichia coli.
    Mizushima T; Ohtsuka Y; Mori H; Miki T; Sekimizu K
    Mol Gen Genet; 1996 Dec; 253(3):297-302. PubMed ID: 9003316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro effect of monensin on BK polyomavirus replication.
    Pietropaolo V; Degener AM; Di Taranto C; Sinibaldi L; Orsi N
    New Microbiol; 1995 Oct; 18(4):341-9. PubMed ID: 8590386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells.
    Sharma BN; Li R; Bernhoff E; Gutteberg TJ; Rinaldo CH
    Antiviral Res; 2011 Oct; 92(1):115-23. PubMed ID: 21798289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro.
    Randhawa P; Farasati NA; Shapiro R; Hostetler KY
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1564-6. PubMed ID: 16569886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.